These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6192484

  • 1. Dipeptidylaminopeptidase IV (DAP IV) activity in normal and malignant T-cell subsets as defined by monoclonal antibodies.
    Wirthmüller R, Dennig D, Oertel J, Gerhartz H.
    Scand J Haematol; 1983 Sep; 31(3):197-205. PubMed ID: 6192484
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dipeptidylaminopeptidase IV (DAP IV) in B- and T-cell leukaemias.
    Andrews C, Crockard AD, San Miguel JF, Catovsky D.
    Clin Lab Haematol; 1985 Sep; 7(4):359-68. PubMed ID: 2869856
    [Abstract] [Full Text] [Related]

  • 4. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
    Feller AC, Parwaresch MR, Lennert K.
    Cancer; 1983 Nov 01; 52(9):1609-12. PubMed ID: 6137274
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneous expression of dipeptidyl-amino-peptidase (DAP IV) in T-cell chronic lymphocytic leukemia.
    Chilosi M, Pizzolo G, Semenzato G, de Rossi G, Pandolfi F.
    Acta Haematol; 1984 Nov 01; 71(4):277-81. PubMed ID: 6426241
    [Abstract] [Full Text] [Related]

  • 6. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS, Golubeva NV, Gureeva TA, Lokshina LA, Polianskaia AM, Samoĭlova RS.
    Biull Eksp Biol Med; 1989 Jul 01; 108(7):85-8. PubMed ID: 2572281
    [Abstract] [Full Text] [Related]

  • 7. Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.
    Invernizzi R, Bertolino G, Girino M, Perseghin P, Michienzi M, Nano R.
    Blut; 1985 May 01; 50(5):277-85. PubMed ID: 2859898
    [Abstract] [Full Text] [Related]

  • 8. Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
    Feller AC, Parwaresch MR, Bartels H, Lennert K.
    Leuk Res; 1982 May 01; 6(6):801-8. PubMed ID: 6759796
    [Abstract] [Full Text] [Related]

  • 9. Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.
    Khalaf MR, Bevan PC, Hayhoe FG.
    J Clin Pathol; 1986 Aug 01; 39(8):891-6. PubMed ID: 2875085
    [Abstract] [Full Text] [Related]

  • 10. Dipeptidyl-amino-peptidase IV (DAP IV) activity in human T-cell subsets.
    Dufer J, Bernard J.
    Acta Haematol; 1984 Aug 01; 72(3):213-4. PubMed ID: 6438989
    [No Abstract] [Full Text] [Related]

  • 11. Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies.
    Feller AC, Parwaresch MR, Lennert K.
    Leuk Res; 1984 Aug 01; 8(3):397-406. PubMed ID: 6379309
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic heterogeneity of leukemic Sézary cells.
    Feller AC, Ziegler A, Sterry W, Goos M, Parwaresch MR.
    Blut; 1983 Dec 01; 47(6):333-41. PubMed ID: 6606455
    [Abstract] [Full Text] [Related]

  • 13. Expression of dipeptidylaminopeptidase-IV in some human T and B cell lines.
    Srivastava MD, Bhargava AK.
    Acta Haematol; 1986 Dec 01; 76(1):25-8. PubMed ID: 2878556
    [Abstract] [Full Text] [Related]

  • 14. Cytochemical reactivity of T mu lymphocytes in human lymphatic tissue for dipeptidylaminopeptidase IV.
    Feller AC.
    Histochem J; 1982 Nov 01; 14(6):889-95. PubMed ID: 6757193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dipeptidylaminopeptidase IV activity in T lymphocyte subsets in B cell non-Hodgkin's lymphomas.
    Cozzi M, Gloghini A, Sulfaro S, Volpe R, Carbone A.
    Hum Pathol; 1989 Oct 01; 20(10):987-93. PubMed ID: 2571558
    [Abstract] [Full Text] [Related]

  • 17. Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients.
    Ramos EL, Turka LA, Leggat JE, Wood IG, Milford EL, Carpenter CB.
    Transplantation; 1989 Mar 01; 47(3):465-71. PubMed ID: 2522253
    [Abstract] [Full Text] [Related]

  • 18. Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.
    Nicholson JK, McDougal JS, Spira TJ, Cross GD, Jones BM, Reinherz EL.
    J Clin Invest; 1984 Jan 01; 73(1):191-201. PubMed ID: 6228564
    [Abstract] [Full Text] [Related]

  • 19. Stimulation and inhibition of human granulopoiesis in vitro by normal and malignant T4- or T8-lymphocyte subpopulations.
    Bonnefoix T, Sotto JJ, Pegourie B, Piccinni MP.
    Exp Hematol; 1987 Jul 01; 15(6):645-51. PubMed ID: 2954841
    [Abstract] [Full Text] [Related]

  • 20. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M, Thivolet J.
    J Clin Immunol; 1982 Jul 01; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.